Arthritis drug shows ‘significant’ promise in severe COVID-19 cases: study
PARIS, France (AFP) — The arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill COVID-19 patients,…
6 years ago
PARIS, France (AFP) — The arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill COVID-19 patients,…
This website uses cookies.